Detection and quantification of cimicoxib, a novel COX-2 inhibitor, in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology.
暂无分享，去创建一个
A. Saba | M. Rouini | M. Giorgi | H. Yun | H. Owen | Tae-Won Kim | R. Ryschanova
[1] I. Emmerich. [New drugs for small animals in 2011]. , 2012, Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere.
[2] M. Giorgi. VETERINARY PHARMACOLOGY: IS IT STILL PHARMACOLOGY’S CINDERELLA? , 2012 .
[3] A. Saba,et al. Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology , 2011, Analytical and bioanalytical chemistry.
[4] S. Meena,et al. An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices. , 2005, Journal of pharmaceutical and biomedical analysis.
[5] S. Budsberg,et al. The coxib NSAIDs: potential clinical and pharmacologic importance in veterinary medicine. , 2005, Journal of veterinary internal medicine.
[6] L. Sorbera,et al. Cimicoxib: Antiarthritic, analgesic, COX-2 inhibitor , 2004 .